GlassScriptPhysician profile
Clayton Li
NPI 1245727858
$968.52
in general payments reported to CMS, 2019-2025
7 companies · $46.96 in 2025
The $46.96 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.83 · 2024: $890 · 2025: $46.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $517.74 | 2024 | Ekosonic, Angiojet Ultra 5000a |
| Cardiva Medical, INC. | $146.45 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $139.50 | 2024 | Ruby Coil |
| Inari Medical, INC. | $54.19 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $31.85 | 2024 | Kyphon Express II Kyphopak Tray |
| Becton, Dickinson and Company | $23.82 | 2025 | Pleurx |
| Sirtex Medical INC | $23.14 | 2025 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.